Avadel Pharmaceuticals plc
Hedge Funds Holdings
Last updated:
Avadel Pharmaceuticals plc‘s stocks are currently a part of 56 hedge funds’ portfolios, which represents 44.41% of the total amount of its stocks outstanding. This makes up a total of 26.68M shares of Avadel Pharmaceuticals plc. Compared to the previous quarter, the number fell by -47.62% or -24.25M shares fewer. As for the holding position changes, 39.29% (22) of current hedge fund investors increased the number of shares held, 19.64% (11) of current holders sold a part of the shares held, and 3.57% (2) closed the holdings completely. 7 hedge funds are new holders of Avadel Pharmaceuticals plc stock in Q1 2023, it is 12.5% of total holders.
Hedge funds holding Avadel Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 72 |
|---|---|
| Q3 2018 | 62 |
| Q4 2018 | 53 |
| Q1 2019 | 42 |
| Q2 2019 | 40 |
| Q3 2019 | 42 |
| Q4 2019 | 43 |
| Q1 2020 | 56 |
| Q2 2020 | 73 |
| Q3 2020 | 77 |
| Q4 2020 | 80 |
| Q1 2021 | 78 |
| Q2 2021 | 80 |
| Q3 2021 | 83 |
| Q4 2021 | 84 |
| Q1 2022 | 84 |
| Q2 2022 | 80 |
| Q3 2022 | 77 |
| Q4 2022 | 83 |
| Q1 2023 | 56 |
Hedge funds changes in Avadel Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 6 | 24 | 20 | 11 | 11 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 13 | 23 | 15 | 6 |
| Q4 2018 | 9 | 7 | 18 | 18 | 1 |
| Q1 2019 | 2 | 8 | 15 | 13 | 4 |
| Q2 2019 | 7 | 11 | 9 | 9 | 4 |
| Q3 2019 | 9 | 9 | 10 | 7 | 7 |
| Q4 2019 | 13 | 10 | 8 | 12 | 0 |
| Q1 2020 | 25 | 7 | 15 | 9 | 0 |
| Q2 2020 | 30 | 27 | 10 | 13 | -7 |
| Q3 2020 | 20 | 25 | 18 | 16 | -2 |
| Q4 2020 | 23 | 21 | 21 | 19 | -4 |
| Q1 2021 | 12 | 24 | 23 | 14 | 5 |
| Q2 2021 | 11 | 26 | 16 | 9 | 18 |
| Q3 2021 | 11 | 28 | 21 | 8 | 15 |
| Q4 2021 | 15 | 24 | 21 | 13 | 11 |
| Q1 2022 | 20 | 20 | 23 | 18 | 3 |
| Q2 2022 | 16 | 24 | 20 | 19 | 1 |
| Q3 2022 | 12 | 20 | 18 | 14 | 13 |
| Q4 2022 | 16 | 25 | 23 | 7 | 12 |
| Q1 2023 | 7 | 22 | 11 | 2 | 14 |
Hedge funds changes in Avadel Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 678,000 | 594,000 |
|---|---|---|
| Q3 2018 | 160,000 | 354,000 |
| Q4 2018 | 0 | 76,000 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 23,000 | 92,000 |
| Q3 2019 | 655,000 | 239,000 |
| Q4 2019 | 3,794,000 | 1,610,000 |
| Q1 2020 | 29,598,000 | 3,624,000 |
| Q2 2020 | 7,338,000 | 4,112,000 |
| Q3 2020 | 1,118,000 | 907,000 |
| Q4 2020 | 1,115,000 | 1,201,000 |
| Q1 2021 | 7,599,000 | 2,967,000 |
| Q2 2021 | 6,675,000 | 1,634,000 |
| Q3 2021 | 16,443,000 | 1,599,000 |
| Q4 2021 | 7,021,000 | 3,663,000 |
| Q1 2022 | 5,483,000 | 2,559,000 |
| Q2 2022 | 2,872,000 | 2,408,000 |
| Q3 2022 | 5,538,000 | 8,970,000 |
| Q4 2022 | 13,736,944 | 12,281,228 |
| Q1 2023 | 3,047,026,000 | 322,432,000 |